文献速递传染病防控与疫情报告免疫规划慢病防控与筛查

维持性透析患者在德尔塔和早期奥密克戎变异株流行期间的SARS-CoV-2感染率和死亡率——美国,2021年6月30日至2022年9月27日

SARS-CoV-2 Infection and Death Rates Among Maintenance Dialysis Patients During Delta and Early Omicron Waves - United States, June 30, 2021-September 27, 2022.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2023-08-11

美国CDC国家医疗安全网络(NHSN)收集2021年6月30日至2022年9月27日维持性透析患者每周SARS-CoV-2感染和COVID-19相关死亡数据。总体感染率为每10,000患者周30.47例,未接种疫苗患者为39.64例,完成基础免疫接种系列患者为27.24例;总体死亡率为每10,000患者周1.74例。在透析机构实施推荐的感染控制措施并确保患者和工作人员及时接种推荐的COVID-19疫苗对限制COVID-19相关发病和死亡至关重要。

要点

  • 维持性透析患者总体SARS-CoV-2感染率为每10,000患者周30.47例。
  • 未接种疫苗患者感染率为每10,000患者周39.64例,完成基础免疫系列患者为27.24例。
  • 总体COVID-19相关死亡率为每10,000患者周1.74例。

核心结论

  • 在透析机构实施推荐的感染控制措施并确保患者和工作人员及时接种推荐的COVID-19疫苗对限制COVID-19相关发病和死亡至关重要。

研究设计与样本

  • 分析使用了NHSN透析机构在2021年6月30日至2022年9月27日期间报告的COVID-19数据,以描述维持性透析患者的SARS-CoV-2感染率和COVID-19相关死亡率。

主要发现

  • 总体感染率为每10,000患者周30.47例。
  • 未接种疫苗患者感染率为每10,000患者周39.64例,完成基础COVID-19疫苗接种系列患者为27.24例。
  • 总体死亡率为每10,000患者周1.74例。

关键数值与推荐

  • SARS-CoV-2感染定义为SARS-CoV-2检测结果阳性。
  • COVID-19相关死亡定义为未从SARS-CoV-2感染中完全康复的患者的死亡。

临床怎么用

  • 在透析机构实施推荐的感染控制措施。
  • 确保患者和工作人员及时接种推荐的COVID-19疫苗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Persons receiving maintenance dialysis are at increased risk for SARS-CoV-2 infection and its severe outcomes, including death. However, rates of SARS-CoV-2 infection and COVID-19-related deaths in this population are not well described. Since November 2020, CDC's National Healthcare Safety Network (NHSN) has collected weekly data monitoring incidence of SARS-CoV-2 infections (defined as a positive SARS-CoV-2 test result) and COVID-19-related deaths (defined as the death of a patient who had not fully recovered from a SARS-CoV-2 infection) among maintenance dialysis patients. This analysis used NHSN dialysis facility COVID-19 data reported during June 30, 2021-September 27, 2022, to describe rates of SARS-CoV-2 infection and COVID-19-related death among maintenance dialysis patients. The overall infection rate was 30.47 per 10,000 patient-weeks (39.64 among unvaccinated patients and 27.24 among patients who had completed a primary COVID-19 vaccination series). The overall death rate was 1.74 per 10,000 patient-weeks. Implementing recommended infection control measures in dialysis facilities and ensuring patients and staff members are up to date with recommended COVID-19 vaccination is critical to limiting COVID-19-associated morbidity and mortality.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Navarrete J, Barone G, Qureshi I, et al. SARS-CoV-2 Infection and Death Rates Among Maintenance Dialysis Patients During Delta and Early Omicron Waves - United States, June 30, 2021-September 27, 2022. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37561674. doi:10.15585/mmwr.mm7232a4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。